At Catalyst by Wellstar, we believe that healthcare must evolve to meet the needs of all patients, especially those whose health outcomes are impacted by social determinants of health (SDOH). We are excited to announce our investment in Alvee Health, a pioneering health equity startup. This positions Catalyst to help lead the charge in addressing the critical gap in healthcare for underserved communities.
Alvee’s AI-powered technology integrates directly with Epic, one of the leading electronic health record (EHR) platforms, allowing healthcare providers to incorporate SDOH data into their workflows. This ensures that issues like food insecurity, housing instability, and transportation challenges are addressed, preventing patients from falling through the cracks due to unreported social factors.
As health equity becomes increasingly vital in the U.S.—where SDOH account for 80% of health outcomes but only 16% of physicians routinely screen for these factors—Alvee’s platform provides real-time insights that not only improve patient care but also help hospitals comply with Centers for Medicare & Medicaid Services (CMS) health equity reporting requirements. This dual capability makes Alvee a scalable solution for enhancing patient outcomes while supporting financial sustainability.
Elise Lockamy-Kassim, Assistant Vice President for Community Health and the Wellstar Center for Health Equity, expressed her enthusiasm for the partnership, stating, “We are thrilled to support Alvee’s mission to improve health outcomes for under-resourced communities. As a healthcare executive continuously seeking health equity solutions, I believe this investment will enhance our ability to collaborate with healthcare systems and provide actionable, data-driven insights to the challenges faced by medically underserved populations. Alvee’s technology aligns with Wellstar’s mission to enhance the health and well-being of every person we serve. We are excited to see how it can help reduce disparities and improve access to quality care.”
Moreover, Alvee’s system assists healthcare organizations in boosting revenue by accurately coding SDOH-related conditions, unlocking higher reimbursement rates and ensuring sustainable models. Hospital administrators benefit from performance dashboards that track health equity metrics, aiding in compliance and continuous improvement.
“We’re thrilled to partner with Alvee Health as they tackle one of the most pressing issues in healthcare today: health equity,” said John D. Cooper, Head of Venture Investment for Catalyst By Wellstar. “By investing in Alvee, we are advancing our mission to deliver innovative solutions that improve patient outcomes and provide care that is inclusive of each patient’s unique needs and environment. Alvee’s approach to embedding SDOH data within clinical workflows offers a game-changing solution to a complex problem.”
Alvee’s impressive growth trajectory and partnerships with key industry players such as Mayo Clinic underscore the scalability of its solutions. This investment is a pivotal step for Catalyst as we continue to prioritize healthcare innovation that aligns with our “Care of Tomorrow” initiative, focusing on technology-driven solutions that make a meaningful difference in patients’ lives.
A pilot project is currently in development to leverage Alvee’s technology within Wellstar’s health service line.
With this investment, Catalyst by Wellstar reaffirms its commitment to leveraging technology and innovation to reduce health disparities and improve patient care across diverse populations. We look forward to seeing how Alvee continues to shape the future of healthcare and drive equitable health outcomes for all.
To learn more about how Catalyst is shaping the future of healthcare and supporting innovative startups like Alvee, visit catalyst.wellstar.org.
To learn more about Alvee, visit https://www.alvee.io.
